BioAge Labs (BIOA) Consolidated Net Income (2023 - 2026)
BioAge Labs (BIOA) posted Consolidated Net Income of -$22.2 million for Q1 2026, down 41.33% sequentially from -$15.7 million in Q4 2025, and down 70.4% YoY from -$75.0 million in Q1 2025.
BioAge Labs (BIOA) Consolidated Net Income (2023 - 2026) Analysis & Trends
BioAge Labs has reported Consolidated Net Income for 4 years, with the latest figure at -$22.2 million in Q1 2026.
- Quarterly Consolidated Net Income fell 70.4% year-over-year to -$22.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$92.0 million (up 35.26% YoY) and the FY2025 annual result came in at -$125.9 million, down 56.33% from the prior year.
- Consolidated Net Income declined to -$22.2 million in Q1 2026 per BIOA's latest filing, from -$15.7 million in the prior quarter.
- Over five years, Consolidated Net Income peaked at -$11.8 million in Q3 2023 and troughed at -$82.2 million in Q3 2024.
- A 4-year average of -$25.1 million and a median of -$15.8 million in 2023 frame the typical range for Consolidated Net Income.
- The sharpest annual moves came in 2024 and 2025: Consolidated Net Income plunged 597.18% in 2024, then jumped 65.27% in 2025.
- Over 4 years, Consolidated Net Income stood at -$15.8 million in 2023, then slumped by 97.86% to -$31.2 million in 2024, then soared by 49.66% to -$15.7 million in 2025, then sank by 41.33% to -$22.2 million in 2026.
- According to Business Quant data, Consolidated Net Income over the past three periods registered -$22.2 million, -$15.7 million, and -$28.6 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Consol Net Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.05 Bn | 43.08 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.39 Bn | 39.74 Bn | 2.15 Bn | -576.00 Mn |
| 3 | Zoetis | 31.86 Bn | 30.18 Bn | 1.05 Bn | 866.00 Mn |
| 4 | Takeda Pharmaceutical | 28.78 Bn | 22.99 Bn | 5.10 Bn | 1.33 Bn |
| 5 | United Therapeutics | 22.25 Bn | 19.59 Bn | 683.80 Mn | 333.00 Mn |
| 6 | Viatris | 18.74 Bn | 17.85 Bn | 1.46 Bn | -118.80 Mn |
| 7 | Neurocrine Biosciences | 15.58 Bn | 15.19 Bn | 935.80 Mn | 144.40 Mn |
| 8 | Elanco Animal Health | 11.92 Bn | 11.39 Bn | 798.00 Mn | 54.00 Mn |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 9.99 Bn | - | - |
| 10 | BioAge Labs | 447.94 Mn | 447.94 Mn | -14.23 Mn | -25.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -157.61 Mn |
| Mar 31, 2026 | -22.21 Mn |
| Dec 31, 2025 | -15.71 Mn |
| Sep 30, 2025 | -28.55 Mn |
| Jun 30, 2025 | -25.56 Mn |
| Mar 31, 2025 | -13.03 Mn |
| Dec 31, 2024 | -31.22 Mn |
| Sep 30, 2024 | -82.20 Mn |
| Jun 30, 2024 | -15.71 Mn |
| Mar 31, 2024 | -14.03 Mn |
| Dec 31, 2023 | -15.78 Mn |
| Sep 30, 2023 | -11.79 Mn |